
Keywords: cardiomyopathy; catecholamine; gene therapy; heart failure; AAV; adeno-associated virus; AC; adenylyl cyclase; AC6mut; AC6 mutant, contains an amino acid substitution that reduces its catalytic activity; Ad5; adenovirus-5; AKAP; A-kinase-anchoring protein